CLSD
Price
$0.77
Change
-$0.04 (-4.94%)
Updated
Jun 27 closing price
Capitalization
59.84M
49 days until earnings call
ZIVO
Price
$14.91
Change
+$0.69 (+4.85%)
Updated
Jun 24 closing price
Capitalization
56.86M
Interact to see
Advertisement

CLSD vs ZIVO

Header iconCLSD vs ZIVO Comparison
Open Charts CLSD vs ZIVOBanner chart's image
Clearside Biomedical
Price$0.77
Change-$0.04 (-4.94%)
Volume$283.05K
Capitalization59.84M
Zivo Bioscience
Price$14.91
Change+$0.69 (+4.85%)
Volume$516
Capitalization56.86M
CLSD vs ZIVO Comparison Chart in %
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. ZIVO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a Buy and ZIVO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CLSD: $0.77 vs. ZIVO: $14.91)
Brand notoriety: CLSD and ZIVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSD: 107% vs. ZIVO: 35%
Market capitalization -- CLSD: $59.84M vs. ZIVO: $56.86M
CLSD [@Biotechnology] is valued at $59.84M. ZIVO’s [@Biotechnology] market capitalization is $56.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileZIVO’s FA Score has 0 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • ZIVO’s FA Score: 0 green, 5 red.
According to our system of comparison, ZIVO is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 3 TA indicator(s) are bullish while ZIVO’s TA Score has 4 bullish TA indicator(s).

  • CLSD’s TA Score: 3 bullish, 5 bearish.
  • ZIVO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ZIVO is a better buy in the short-term than CLSD.

Price Growth

CLSD (@Biotechnology) experienced а -8.31% price change this week, while ZIVO (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Reported Earning Dates

CLSD is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLSD($59.8M) and ZIVO($56.9M) have the same market capitalization . CLSD YTD gains are higher at: -18.947 vs. ZIVO (-30.651). ZIVO has higher annual earnings (EBITDA): -16.29M vs. CLSD (-19.77M). CLSD has more cash in the bank: 13.6M vs. ZIVO (517K). CLSD has less debt than ZIVO: CLSD (619K) vs ZIVO (975K). CLSD has higher revenues than ZIVO: CLSD (3.76M) vs ZIVO (122K).
CLSDZIVOCLSD / ZIVO
Capitalization59.8M56.9M105%
EBITDA-19.77M-16.29M121%
Gain YTD-18.947-30.65162%
P/E RatioN/AN/A-
Revenue3.76M122K3,085%
Total Cash13.6M517K2,631%
Total Debt619K975K63%
FUNDAMENTALS RATINGS
CLSD vs ZIVO: Fundamental Ratings
CLSD
ZIVO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8356
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZIVO's Valuation (82) in the null industry is in the same range as CLSD (90) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's Profit vs Risk Rating (100) in the null industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's SMR Rating (100) in the null industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

ZIVO's Price Growth Rating (56) in the null industry is in the same range as CLSD (83) in the Pharmaceuticals Major industry. This means that ZIVO’s stock grew similarly to CLSD’s over the last 12 months.

CLSD's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as ZIVO (100) in the null industry. This means that CLSD’s stock grew similarly to ZIVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSDZIVO
RSI
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZIVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYDVF0.220.01
+5.19%
CENTURY LITHIUM CORP.
GEAHF1.69N/A
N/A
Great Eagle Holdings Ltd.
IVSBF28.28N/A
N/A
Investors AB
BVAXF0.03N/A
N/A
BioVaxys Technology Corp.
TKAMY10.60-0.01
-0.09%
ThyssenKrupp AG

CLSD and

Correlation & Price change

A.I.dvisor tells us that CLSD and ACLX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSD and ACLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
-5.06%
ACLX - CLSD
28%
Poorly correlated
+0.90%
INBX - CLSD
28%
Poorly correlated
-2.43%
BOLT - CLSD
27%
Poorly correlated
-2.43%
ATRA - CLSD
27%
Poorly correlated
N/A
JAZZ - CLSD
26%
Poorly correlated
-0.57%
More

ZIVO and

Correlation & Price change

A.I.dvisor tells us that ZIVO and MDXXF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZIVO and MDXXF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZIVO
1D Price
Change %
ZIVO100%
N/A
MDXXF - ZIVO
22%
Poorly correlated
+7.07%
ATXS - ZIVO
21%
Poorly correlated
N/A
ETXPF - ZIVO
21%
Poorly correlated
N/A
COGT - ZIVO
20%
Poorly correlated
-3.14%
CLSD - ZIVO
20%
Poorly correlated
-5.06%
More